Bibliographical noteFunding Information:
FINANCIAL/NONFINANCIAL DISCLOSURES: The authors have reported to CHEST the following: T. S. V. reports research funding from the NIH, Agency for Healthcare Research and Quality (AHRQ), American Thoracic Society , and Society of Critical Care Medicine . I. D. P. reports research funding from the National Institutes of Health (NIH), Centers for Disease Control and Prevention , and Janssen Pharmaceuticals and funding to his institution from Asahi Kasei Pharma and Regeneron, all outside the present work. K. S. M. reports funding from the NIH and Roivant/Kinevant Sciences, outside of the submitted work. J. A. P. reports research funding from the NIH. K. C. V. is supported by resources from the VA Portland Health Care System. C. L. H. reports funding from the NIH and American Lung Association. None declared (A. S., S. E. J.)
FUNDING/SUPPORT: This work was supported by the National Institutes of Health (NIH) [3U01HL123009-06S1, U01HL123009, U01HL122998, U01HL123018, U01HL123023, U01HL123008, U01HL123031, U01HL123004, U01HL123027, U01HL123010, U01HL123033, U01HL122989, U01HL123022, and U01HL123020]. The Research Electronic Data Capture data tools used in this study were supported, in part, by the NIH/ National Center for Advancing Translational Sciences [UL1TR000445]. T. S. V. was supported by the Agency for Healthcare Research and Quality (AHRQ) [R01HS028038] and the NIH [K23HL140165]. K. S. M. was supported by the NIH [K23HL130648]. C. L. H. was supported by the NIH [K24HL141526].
PubMed: MeSH publication types
- Research Support, U.S. Gov't, P.H.S.
- Research Support, N.I.H., Extramural